DOSSIER · 13F-HR · Q2 2026

Data Collective IV GP, LLC

$79M in tracked AUM across 4 positions as of Q2 2026.

DC
CIK 0001664974 · last filed Jun 30, 2026
Total AUM
$79M
as of Q2 2026
Holdings
4
positions
Whale Score
67
67
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

Portfolio Overview

Data Collective IV GP, LLC presents a highly concentrated, high-conviction investment portfolio characterized by significant volatility and active management. As of the reporting period ending September 30, 2025, the firm’s total assets under management (AUM) stood at approximately $67.98 million, representing a sharp decline of 47.7% from the previous quarter's $129.91 million. This dramatic reduction in portfolio value is attributable to a combination of active asset li...

The portfolio exhibits extreme concentration, holding only four securities. This lack of diversification suggests an investment philosophy focused on high-alpha opportunities rather than risk mitigation through broad indexing. The top two positions—Evolv Technologies and Recursion Pharmaceuticals—account for approximately 98.2% of the total portfolio value, indicating that the firm's performance is inextricably linked to the fortunes of these two specific companies.

Key Holdings

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
EVLV
Evolv Technologies Holdings, Inc.
$27M4.6M33.9%
02
Y4000A102
Horizon Quantum Holdings Ltd
$25M915K32.3%
03
RXRX
Recursion Pharmaceuticals, Inc.
$22M5.9M27.8%
04
DFTX
Definium Therapeutics, Inc. (MindMed)
$5M100K6.0%

Filing history

2026Q2Jun 30
$79M 34.3%
4 positionsView →
2025Q4Dec 31
$59M 13.9%
3 positionsView →
2025Q3Sep 30
$68M 47.7%
4 positionsView →
2025Q2Jun 30
$130M 108.7%
5 positionsLocked
2025Q1Mar 31
$62M 72.5%
4 positionsLocked
2024Q4Dec 31
$226M 38.4%
6 positionsLocked
2024Q3Sep 30
$163M 14.6%
6 positionsLocked
2024Q2Jun 30
$143M 23.7%
6 positionsLocked
2024Q1Mar 31
$115M 4.6%
5 positionsLocked
2023Q4Dec 31
$121M 14.4%
5 positionsLocked
2023Q3Sep 30
$106M 21.8%
5 positionsLocked
2023Q2Jun 30
$135M 43.9%
6 positionsLocked
Showing 12 of 18